# Hummingbird Bioscience

> Clinical-stage precision biotherapeutics company (The Galen, Singapore Science Park, with US
> operations) discovering and developing antibody-based medicines — including next-generation
> antibody-drug conjugates — for hard-to-treat cancers and autoimmune disease. Hummingbird
> Bioscience sells drug programs and partnerships, not software: as of 2026-08-22 it publishes
> **no API, no SDK, no developer portal and no machine-readable contract of any kind**. Agents
> should not expect a programmable surface here.

## About

- [Website](https://hummingbirdbioscience.com/): Corporate site (WordPress). Note: the origin
  answers automated clients with a SiteGround "Robot Challenge Screen" (HTTP 202,
  `sg-captcha: challenge`), so machine reads of any page on this host require solving a
  JavaScript proof-of-work challenge.
- [About Us](https://hummingbirdbioscience.com/about-us/): Company, leadership, locations.
- [Science](https://hummingbirdbioscience.com/science/): Rational Antibody Discovery (RAD)
  platform — computational target and epitope modelling, proprietary immunization strategies,
  Abvantage mice.
- [Antibody Platform](https://hummingbirdbioscience.com/antibody-platform/)
- [ADC Platform](https://hummingbirdbioscience.com/adc-platform/): Linker-payload chemistry.
- [Pipeline](https://hummingbirdbioscience.com/pipeline/): HMBD-001 (anti-HER3 mAb), HMBD-501
  (HER3-targeted ADC; first patient dosed January 2026). HMBD-002 (anti-VISTA) was licensed to
  Percheron Therapeutics in 2025.
- [Publications](https://hummingbirdbioscience.com/publications/)
- [News](https://hummingbirdbioscience.com/news/)
- [Partnering](https://hummingbirdbioscience.com/partnering/): Business-development contact for
  licensing and collaboration — the company's only intake surface.
- [Patients](https://hummingbirdbioscience.com/patients/)
- [Careers](https://hummingbirdbioscience.com/careers/)
- [Contact](https://hummingbirdbioscience.com/contact/)
- [Privacy Policy](https://hummingbirdbioscience.com/privacy-policy/)

## Code

- [GitHub organization](https://github.com/hummingbirdbio): "Hummingbird Bioscience", Singapore,
  it@hummingbirdbio.com. 0 public repositories; 2 public gists (internal JupyterLab R/conda kernel
  notes). No published source, no SDK.

## APIs

None. Contract discovery run 2026-08-22 against hummingbirdbioscience.com found no OpenAPI,
Swagger, GraphQL SDL, AsyncAPI, gRPC/Protobuf, WSDL, MCP server or A2A agent card, and no
api./docs./developer./portal. subdomain resolves. hummingbirdbio.com redirects to the same
corporate site.

## Artifacts published by API Evangelist

- [apis.yml](apis.yml): APIs.json 0.20 provider profile.
- [Well-known probe](well-known/hummingbird-bioscience-well-known.yml): recorded absence — every
  /.well-known/ path, including a nonsense control path, returns the same bot-challenge body.
- [Packages](packages/hummingbird-bioscience-packages.yml): recorded absence across npm, PyPI,
  RubyGems, crates.io, Packagist and GitHub.
- [Domain security](security/hummingbird-bioscience-domain-security.yml): probed TLS 1.3, no HSTS,
  no DNSSEC, no CAA, no apex SPF, no DMARC.